INC Research/inVentiv Health Becomes Syneos Health™
04. Januar 2018 09:28 ET
|
INC Research, LLC
RALEIGH, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More...
INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference
14. Dezember 2017 18:09 ET
|
INC Research, LLC
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
INC Research/inVentiv Health Strengthens Leadership of Commercial Solutions
07. Dezember 2017 07:12 ET
|
INC Research, LLC
RALEIGH, N.C., Dec. 07, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (NASDAQ:INCR), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO (Contract...
INC Research/inVentiv Health Reports Third Quarter 2017 Results
09. November 2017 06:20 ET
|
INC Research, LLC
Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively.Combined Company adjusted net service revenue of $766.6...